Search
Collegium Pharmaceutical Inc
COLLAdd to Watchlist
35.390USD
-0.590-1.64%
Close 07-31 16:00（ET）Quotes delayed by 15 min
1.15BMarket Cap
15.00P/E TTM
Revenue Breakdown
Currency: USDUpdated: Mon, Apr 6
Currency: USDUpdated: Mon, Apr 6
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
By BusinessUSD
Name
Revenue
Proportion
Nucynta IR
336.96M
43.17%
Belbuca
221.65M
28.40%
Xtampza ER
199.31M
25.53%
Jomay PM
148.86M
19.07%
Nucynta ER
80.98M
10.38%
Symproic
14.45M
1.85%
By RegionUSD
Name
Revenue
Proportion
United States
780.57M
100.00%
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
Nucynta IR
336.96M
43.17%
Belbuca
221.65M
28.40%
Xtampza ER
199.31M
25.53%
Jomay PM
148.86M
19.07%
Nucynta ER
80.98M
10.38%
Symproic
14.45M
1.85%